A new therapeutic, DISC-0974, shows remarkable affinity for RGMC, this vital factor involved during embryonic differentiation. Preclinical data suggest that inhibiting RGMC/HFE2 function with this therapeutic results https://www.targetmol.com/compound/disc_0974